Assetmark, Inc Myriad Genetics Inc Transaction History

Assetmark, Inc

$32.1 Billion
Q2 2024

19 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2023 Oct 27, 2023	BUY	$15.99 - $23.22 $815 - $1,184	51 Added 38.93%	182 $2,000
Q1 2023 May 05, 2023	SELL	$15.26 - $23.75 $1,312 - $2,042	-86 Reduced 39.63%	131 $3,000
Q4 2022 Feb 10, 2023	BUY	$14.51 - $20.99 $14 - $20	1 Added 0.46%	217 $3,000
Q2 2022 Aug 03, 2022	BUY	$16.45 - $25.88 $2,023 - $3,183	123 Added 132.26%	216 $4,000
Q1 2022 May 13, 2022	SELL	$22.67 - $28.01 $90 - $112	-4 Reduced 4.12%	93 $2,000
Q4 2021 Feb 14, 2022	BUY	$24.13 - $32.63 $168 - $228	7 Added 7.78%	97 $3,000
Q2 2021 Aug 16, 2021	SELL	$25.39 - $32.61 $126 - $163	-5 Reduced 5.26%	90 $3,000
Q1 2021 May 14, 2021	SELL	$19.92 - $31.6 $278 - $442	-14 Reduced 12.84%	95 $3,000
Q2 2020 Aug 11, 2020	BUY	$10.69 - $16.49 $406 - $626	38 Added 53.52%	109 $1,000
Q1 2020 May 12, 2020	BUY	$9.78 - $29.53 $97 - $295	10 Added 16.39%	71 $1,000
Q4 2019 Feb 11, 2020	BUY	$20.93 - $35.1 $188 - $315	9 Added 17.31%	61 $2,000
Q3 2019 Nov 13, 2019	SELL	$22.08 - $47.08 $1,148 - $2,448	-52 Reduced 50.0%	52 $1,000
Q2 2019 Aug 14, 2019	BUY	$22.67 - $35.0 $657 - $1,015	29 Added 38.67%	104 $3,000
Q1 2019 May 14, 2019	SELL	$26.93 - $34.7 $215 - $277	-8 Reduced 9.64%	75 $2,000
Q4 2018 Feb 13, 2019	SELL	$27.23 - $45.56 $1,334 - $2,232	-49 Reduced 37.12%	83 $2,000
Q3 2018 Nov 13, 2018	SELL	$37.57 - $50.34 $601 - $805	-16 Reduced 10.81%	132 $6,000
Q2 2018 Aug 01, 2018	SELL	$27.75 - $40.17 $55 - $80	-2 Reduced 1.33%	148 $6,000
Q1 2018 May 16, 2018	SELL	$28.83 - $41.01 $144 - $205	-5 Reduced 3.23%	150 $4,000
Q4 2017 Feb 13, 2018	BUY	$28.45 - $37.14 $4,409 - $5,756	155	155 $5,000

Others Institutions Holding MYGN

# of Institutions

238

Shares Held

92.7M

Call Options Held

117K

Put Options Held

113K

Black Rock Inc. New York, NY

15.2M
Shares

$333 Million
0.01% of portfolio
Vanguard Group Inc Valley Forge, PA

10.1M
Shares

$221 Million
0.0% of portfolio
Wellington Management Group LLP Boston, MA

8.26M
Shares

$181 Million
0.04% of portfolio
Camber Capital Management LP Boston, MA

5.5M
Shares

$121 Million
3.72% of portfolio
Israel Englander Millennium Management LLC | New York, Ny

4.4M
Shares

$96.6 Million
0.05% of portfolio

View Full List

About MYRIAD GENETICS INC

Ticker MYGN
Exchange NASDAQ
Sector Healthcare
Industry Diagnostics & Research
Shares Outstandng 80,634,800
Market Cap $1.77B
Description
Myriad Genetics, Inc., a genetic testing and precision medicine company, develops and commercializes genetic tests in the United States and internationally. The company offers molecular diagnostic tests for use in oncology, and women's and mental health applications. It provides MyRisk Hereditary Cancer Test, a DNA sequencing test for assessing ...

More about MYGN

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Assetmark, Inc, based on Form 13F filings with the SEC.

News

Stay updated on Assetmark, Inc with notifications on news.

Account